000 01330 a2200397 4500
005 20250517014240.0
264 0 _c20160314
008 201603s 0 0 eng d
022 _a1526-4610
024 7 _a10.1111/head.12500
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMarchenko, Alexander
245 0 0 _aPregnancy outcome following prenatal exposure to triptan medications: a meta-analysis.
_h[electronic resource]
260 _bHeadache
_cApr 2015
300 _a490-501 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Review
650 0 4 _aAnimals
650 0 4 _aCase-Control Studies
650 0 4 _aCohort Studies
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aMigraine Disorders
_xdrug therapy
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications
_xdrug therapy
650 0 4 _aPregnancy Outcome
_xepidemiology
650 0 4 _aPrenatal Exposure Delayed Effects
_xchemically induced
650 0 4 _aTryptamines
_xadverse effects
700 1 _aEtwel, Fatma
700 1 _aOlutunfese, Olukayode
700 1 _aNickel, Cheri
700 1 _aKoren, Gideon
700 1 _aNulman, Irena
773 0 _tHeadache
_gvol. 55
_gno. 4
_gp. 490-501
856 4 0 _uhttps://doi.org/10.1111/head.12500
_zAvailable from publisher's website
999 _c24587635
_d24587635